May 6, 2020—Hamburg, Germany—BioAgilytix, a leading provider of contract bioanalytical testing services with specialization in large molecule bioanalysis, has welcomed Frank Horling, Ph.D. to its leadership team as General Manager, Europe. In this role, Dr. Horling will lead Operations, Finance, HR, and Facilities for BioAgilytix’s European business and its laboratory located in Hamburg, Germany.
Dr. Horling brings with him almost two decades of scientific and leadership experience in the pharmaceutical and biotechnology industry. Most recently, he worked at IMC University of Applied Sciences Krems in Austria where he was Co-Head of the Research Institute for Applied Bioanalytics and Drug Development. Prior to that role, he was the Associate Director of R&D at Shire and has also held senior scientific management positions at Baxalta and Baxter Healthcare. Dr. Horling received his Ph.D. from the University of Bielefeld in Physiology and Biochemistry and his MSc in Toxicology from the Medical University Vienna.
“We’re very excited to have Frank join our team as he knows the science, the industry, and has worked with BioAgilytix in the past as a customer,” said Jim Datin, President and Chief Executive Officer of BioAgilytix. “He has seen firsthand the high standards we hold ourselves to for our clients, and he values customer satisfaction, quality science, and employee engagement as much as we do. His insights will help us ensure our European team has everything they need to continue to meet our clients’ large molecule demands and advance quality partnerships with both current and new EU customers.”
“BioAgilytix’s leading reputation for scientific and service rigor is rightly earned, as I have experienced it as a customer myself,” said Dr. Horling. “I’m thrilled for the opportunity to join their team and be part of delivering these world-class services to sponsors in Europe and across the globe.”
BioAgilytix is a leading bioanalytical testing laboratory specializing in large molecule bioanalysis. With US headquarters in North Carolina’s Research Triangle area, a laboratory in Boston, Massachusetts, and European headquarters in Hamburg, Germany, BioAgilytix provides global services for biomarkers, immunogenicity, PK, and cell-based assays supporting the development and release testing of biologics across a number of industries and disease states. BioAgilytix offers assay development, validation, and sample analysis under non-GLP, GLP, and GCP, as well as GMP quality control testing (i.e. product release testing, stability testing, etc.). We also offer diagnostic testing services through our Boston laboratory.
BioAgilytix’s team of highly experienced scientific and QA professionals ensures high quality science, data integrity, and regulatory compliance through all phases of clinical development, and is a trusted partner to many of the top global pharmaceutical and biotech companies. For more information, visit www.bioagilytix.com.